FIDELITY & GUARANTY LIFE INSURANCE CO sold $584K of CCAP

FIDELITY & GUARANTY LIFE INSURANCE CO sold 55,000 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.62 ($10.60–$10.62, $0.58M total) across 2 trades over 2026-08-28 to 2026-08-31 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · FIDELITY & GUARANTY LIFE INSURANCE CO
Published Sep 1, 2026, 3:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 4:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CCAP
Bearish
medium confidence
Mentioned
$CCAP
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCAPBearishLow
01

Why it matters

The insider sale reduces a major shareholder's stake but is executed via a pre‑arranged plan, limiting its predictive power.

02

Market read

Primary disclosure of an insider sale; modest trading relevance for CCAP.

03

What to watch

The 10b5‑1 plan indicates the sale was pre‑scheduled, reducing the informational value of the transaction.

Relevance 4/10Novelty 5/10Timing: filed Sep 1 after market close

Background

Crescent Capital BDC, Inc. (CCAP) is a publicly traded business development company focused on middle‑market lending.

Company-level read

Ticker impact

$CCAPBearishMedium confidence
Context

Fidelity & Guaranty Life Insurance sold 55,000 CCAP shares for $583,850 via a 10b5‑1 plan, reducing its stake to 4,017,564 shares.

Expected impact

Modest downward pressure; price may dip 1‑2% on the news.

Evidence & confidence

The sale size is modest relative to holdings, but the insider is a large shareholder; market may interpret the sale as a negative signal.

Market effects

Minimal impact on the BDC sector; similar insider sales have limited broader effect.

None

None

Counterpoint

The sale could be routine portfolio rebalancing under a pre‑arranged plan, not a bearish signal.

Key entities

  • Fidelity & Guaranty Life Insurance Co.

    Reporter of the Form 4 filing, holding a 10% ownership position in CCAP.

  • Crescent Capital BDC, Inc.

    The company whose shares were sold.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CCAPHigh

Crescent Capital Q3 2026 slides: earnings beat, $50M buyback unveiled

Crescent Capital BDC (CCAP) reported Q3 2026 earnings of $0.37 per share, beating estimates. The company announced a $50M share buyback and a joint venture to reduce leverage. Shares rose 6.82% in after-hours trading to $9.87, still below NAV. Portfolio assets reached $1.6B, with 91% in senior secured positions. Net investment income declined year-over-year, and NAV per share fell 8%.

$CCAPMed

Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.34 Per Share and Announces a $50 Million Share Repurchase Program LOS ANGELES, November 9, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ

$CCAPMed

Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results; Declares a Third Quarter Base Dividend of $0.34 Per Share LOS ANGELES, August 10, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.36